GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KORU Medical Systems Inc (NAS:KRMD) » Definitions » Cyclically Adjusted PS Ratio

KORU Medical Systems (KORU Medical Systems) Cyclically Adjusted PS Ratio : 3.72 (As of Jun. 02, 2024)


View and export this data going back to 1996. Start your Free Trial

What is KORU Medical Systems Cyclically Adjusted PS Ratio?

As of today (2024-06-02), KORU Medical Systems's current share price is $2.12. KORU Medical Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.57. KORU Medical Systems's Cyclically Adjusted PS Ratio for today is 3.72.

The historical rank and industry rank for KORU Medical Systems's Cyclically Adjusted PS Ratio or its related term are showing as below:

KRMD' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.23   Med: 4.76   Max: 33.82
Current: 3.75

During the past years, KORU Medical Systems's highest Cyclically Adjusted PS Ratio was 33.82. The lowest was 1.23. And the median was 4.76.

KRMD's Cyclically Adjusted PS Ratio is ranked worse than
63.92% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.155 vs KRMD: 3.75

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

KORU Medical Systems's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.179. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


KORU Medical Systems Cyclically Adjusted PS Ratio Historical Data

The historical data trend for KORU Medical Systems's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KORU Medical Systems Cyclically Adjusted PS Ratio Chart

KORU Medical Systems Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.24 16.19 6.92 7.21 4.50

KORU Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.24 6.56 5.01 4.50 4.17

Competitive Comparison of KORU Medical Systems's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KORU Medical Systems's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where KORU Medical Systems's Cyclically Adjusted PS Ratio falls into.



KORU Medical Systems Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

KORU Medical Systems's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.12/0.57
=3.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, KORU Medical Systems's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.179/131.7762*131.7762
=0.179

Current CPI (Mar. 2024) = 131.7762.

KORU Medical Systems Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201402 0.072 99.057 0.096
201405 0.071 100.373 0.093
201408 0.067 100.352 0.088
201411 0.070 99.635 0.093
201502 0.091 99.032 0.121
201505 0.069 100.333 0.091
201508 0.083 100.548 0.109
201511 0.083 100.135 0.109
201602 0.087 100.040 0.115
201605 0.079 101.355 0.103
201608 0.083 101.617 0.108
201611 0.084 101.829 0.109
201702 0.078 102.779 0.100
201706 0.101 103.349 0.129
201709 0.101 104.136 0.128
201803 0.106 105.290 0.133
201806 0.118 106.317 0.146
201809 0.119 106.507 0.147
201812 0.112 105.998 0.139
201903 0.127 107.251 0.156
201906 0.136 108.070 0.166
201909 0.168 108.329 0.204
201912 0.155 108.420 0.188
202003 0.159 108.902 0.192
202006 0.191 108.767 0.231
202009 0.138 109.815 0.166
202012 0.093 109.897 0.112
202103 0.124 111.754 0.146
202106 0.124 114.631 0.143
202109 0.136 115.734 0.155
202112 0.147 117.630 0.165
202203 0.140 121.301 0.152
202206 0.146 125.017 0.154
202209 0.172 125.227 0.181
202212 0.162 125.222 0.170
202303 0.163 127.348 0.169
202306 0.152 128.729 0.156
202309 0.153 129.860 0.155
202312 0.157 129.419 0.160
202403 0.179 131.776 0.179

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


KORU Medical Systems  (NAS:KRMD) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


KORU Medical Systems Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of KORU Medical Systems's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


KORU Medical Systems (KORU Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on home and specialty infusion solutions. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Executives
Manko Joseph M. Jr. 10 percent owner 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Kenneth E Miller officer: Chief Commercial Officer 26 MOUNTAINVIEW RD, WARREN NJ 07059
Edward Wholihan director C/O ALLENA PHARMACEUTICALS, INC., ONE NEWTOWN EXECUTIVE PARK SUITE 202, NEWTON MA 02462
Linda M Tharby officer: President and CEO BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Robert Cascella director C/O HOLOGIC, INC., BEDFORD MA 01730
Lafrence Andrew D.c. officer: Chief Financial Officer C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Thomas Edward Adams officer: Interim CFO 524 WOODLAND AVENUE, BRIELLE NJ 08730
Brian Case officer: Chief Technology Officer 424 CYPRUS CIR, LAKE VILLA IL 60046-8629
Shahriar Matin director 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Donna French director 25 SEARSVILLE COURT, HILLSBOROUGH CA 94010
Donald B Pettigrew officer: Pres./Chief Commercial Officer 7871 ENGEN LOOP, PARK CITY UT 84098
Karen Fisher officer: CFO 24 CARPENTER ROAD, CHESTER NY 10918
Daniel S Goldberger director 24 CARPENTER ROAD, CHESTER NY 10918
R John Fletcher director C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Horton Freedom, L.p. 10 percent owner 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103